Bioactive Compounds for the Management of Hypertriglyceridemia: Evidence From Clinical Trials and Putative Action Targets

Hypertriglyceridemia refers to the presence of elevated concentrations of triglycerides (TG) in the bloodstream (TG >200 mg/dL). This lipid alteration is known to be associated with an increased risk of atherosclerosis, contributing overall to the onset of atherosclerotic cardiovascular disease (...

Descripción completa

Detalles Bibliográficos
Autores principales: Schiano, Elisabetta, Annunziata, Giuseppe, Ciampaglia, Roberto, Iannuzzo, Fortuna, Maisto, Maria, Tenore, Gian Carlo, Novellino, Ettore
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Nutrition
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7734325/
https://www.ncbi.nlm.nih.gov/pubmed/33330588
http://dx.doi.org/10.3389/fnut.2020.586178

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7734325/
https://www.ncbi.nlm.nih.gov/pubmed/33330588
http://dx.doi.org/10.3389/fnut.2020.586178

Ejemplares similares